---
title: "Docebo (DCBO) Gets a Buy from CIBC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295426302.md"
description: "CIBC analyst Erin Kyle maintained a Buy rating on Docebo (DCBO) with a $29.50 price target. Additionally, ATB Cormark Capital Markets also upheld a Buy rating for the stock, setting a C$44.00 price target."
datetime: "2026-08-10T14:45:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295426302.md)
  - [en](https://longbridge.com/en/news/295426302.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295426302.md)
generator: "portal-rs"
---

# Docebo (DCBO) Gets a Buy from CIBC

CIBC analyst Erin Kyle maintained a Buy rating on Docebo today and set a price target of $29.50.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Kyle is a 2-star analyst with an average return of 0.1% and a 48.48% success rate. Kyle covers the Technology sector, focusing on stocks such as D2L, Docebo, and Dye & Durham.

In a report released today, ATB Cormark Capital Markets also maintained a Buy rating on the stock with a C$44.00 price target.

### Related Stocks

- [DCBO.US](https://longbridge.com/en/quote/DCBO.US.md)
- [CM.US](https://longbridge.com/en/quote/CM.US.md)

## Related News & Research

- [Stocks in Play: Docebo Inc.](https://longbridge.com/en/news/296629949.md)
- [Docebo Inc. Announces Substantial Issuer Bid Price Increase and Extension | DCBO Stock News](https://longbridge.com/en/news/296612706.md)
- [BioSyent GAAP EPS of C$0.25, revenue of C$19.87M](https://longbridge.com/en/news/296538491.md)
- [CIBC Keeps Their Buy Rating on Omai Gold Mines (OMG)](https://longbridge.com/en/news/296814288.md)
- [CIBC Gives a Sell Rating to Transat AT V & VV (TRZ)](https://longbridge.com/en/news/296805028.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**